Navigation Links
HIV Drugs Provide Breast-Fed Babies With Some Protection
Date:7/22/2009

Treating infected mothers, giving meds to infant both beneficial in African study

WEDNESDAY, July 22 (HealthDay News) -- Antiretroviral drugs appear safe and effective in helping prevent the transmission of HIV from mother to child through breast milk, a new international study has found.

The researchers found that giving daily antiretroviral syrup to breast-feeding infants or putting their HIV-infected mothers on highly active antiretroviral drugs significantly lowered the child's chances of contracting the virus that causes AIDS. The chance of a mother with HIV transmitting the virus through breast-feeding is about one in five.

The results of the Breastfeeding, Antiretrovirals and Nutrition (BAN) study, conducted in more than 2,000 HIV-infected mother-child pairs in Malawi in Africa, are scheduled to be presented in South Africa Wednesday at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.

"This is an exciting development," lead investigator Dr. Charles van der Horst, a professor in the University of North Carolina School of Medicine, said in a university news release. "We may be able to spare mothers in the developing world a horrible choice by offering them an effective method for preventing transmission of HIV during breast-feeding."

Breast milk is the source of infection for about half of the 420,000 infants who are infected with HIV annually, the study authors noted. This is a particular problem in some poor countries where HIV-infected mothers risk infecting their babies or having to use more expensive formula that is also subject to contamination from local water supplies.

In the BAN study, HIV-infected mothers and their babies were randomly assigned to one of three groups: infant antiretroviral syrup, maternal medication, or no treatment following birth. After 28 weeks, 7.6 percent of the infants in the group that did not receive any treatment had HIV or died, compared with 4.7 percent of infants whose mothers took antiretroviral medication, and 2.9 percent of the infants taking the antiretroviral syrup, the researchers found.

More information

The University of North Carolina School of Medicine has more about the BAN study.



-- Kevin McKeever



SOURCE: University of North Carolina School of Medicine, news release, July 22, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drugs Provide Breast-Fed Babies With Some Protection
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: